ClinicalTrials.gg
RecruitingNCT06253325MMICSUpdated Dec 2, 2024

Early Detection of At-risk Septic Patients

An observational study in Sepsis, sponsored by University Hospital Southampton NHS Foundation Trust. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-12-02.

Sponsored by University Hospital Southampton NHS Foundation Trust · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2025, 1 year 3 months ago, but the record still lists the study as recruiting.
  • Started Jan 2024; still recruiting 2 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
60
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 95 studies in Sepsis with a site in United Kingdom — 14 open to participants now, 14 under way, 1 of them phase 3. Sepsis · United Kingdom.

Planned enrollment
37th of 49
60 · median 180
Started
2024
with 4 others
Observational
49 of 95
11 open now
Primary completion
2025-08
later than 2 of 13 live
Registered
88th of 95
by date

Among the 95 studies in Sepsis with a site in United Kingdom, this one is the 37th largest by planned enrollment of the 49 observational ones that give a count, is one of 5 that started in 2024, is one of 49 observational ones, reaches primary completion later than 2 of the 13 other live ones, and was the 88th registered.

Sepsis

2,425 studies on the registry are indexed under Sepsis; 543 are open to participants now.

Browse Sepsis studies →

Open to participants now

14 of the 95 studies in Sepsis with a site in United Kingdom are open now. Recruiting first, the newest first:

8 more — sign in →

All 14 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 319 Sepsis studies recruiting now, 212 (66%) set no upper age limit and 52 (16%) stop at 75 or younger; 67 take children under 18; 43 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 95 studies in Sepsis with a site in United Kingdom, or all of them as a file.
02

Study summary

The purpose of this study is to determine whether additional investigations used in other parts of healthcare can be used in the Emergency Department to identify critically ill patients quicker than usual care.

Read the detailed description

The investigators intend to recruit 56 patients with suspected sepsis who attend the Emergency Department. The investigators want to use a device to monitor tissue oxygen levels when they first come into the Emergency Department as well as the change in tissue oxygen levels when a tourniquet is applied for 3 minutes. The investigators will take novel blood tests when the patient is having their routine bloods. Finally, the investigators will use a special camera to take specialised pictures of the small blood vessels under the tongue which will show blood flow through these vessels. The investigators will follow the recruited patients and determine if our extra data is better at determining who needs critical care. A significant proportion of patients may be too unwell or too distressed to consent to be part of this study. At the earliest opportunity, the investigators will ask patients when they have been stabilised and are able to give consent. If they say no, they will be removed from the study and their care will not be affected by this decision.

The results could help us identify septic shock as early as possible so that these unwell patients are identified early and get the correct treatment they need. This could mean starting advanced treatments usually found in the Intensive Care Unit very early on in a patient's journey.

03

Conditions studied

  • Sepsis

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients presenting to the Emergency Department with their illness possibly caused by sepsis

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Differential diagnosis which includes infection
  2. Change in the quick Sequential Organ Failure Assessment (qSOFA) ≥2 or National Early Warning Score 2 (NEWS2) score ≥5
  3. Aged ≥18 years

Exclusion criteria

Exclusion Criteria:

  1. Traumatic injury
  2. Rockwood frailty score ≥6
  3. Critical care therapy previously believed to not be in patient's best interests
  4. Critical care therapies-initiated pre-hospital. Critical care therapies defined as:

    4.1 Mechanical ventilation 4.2 Vasopressor/inotrope therapy 4.3 Sedation or a general anaesthetic 4.4 Pre-hospital transfusion of blood products 4.5 Extra-corporeal support

  5. Advanced directive refusing critical care therapies.
  6. Acute cardiac failure
  7. Active gastrointestinal bleed
  8. Massive pulmonary embolism
  9. ICU admission declined by critical care team
  10. Treated in an acute hospital \<6 hours before presentation to the Emergency Department
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
60 participants (estimated)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • Patients presenting to the Emergency Department with suspected sepsis

    Patients who present with potential sepsis. This is characterised by their illness suspected to be from an infection and significantly unwell defined by one of two scoring systems, either the National Early Warning Score or quick Sequential Organ Failure Assessment

    Diagnostic Test: Measuring tissue oxygenation · Diagnostic Test: Procalcitonin · Diagnostic Test: Mid-regional proadrenomedullin · Diagnostic Test: Hand-held video microscope

Interventions

  • Diagnostic testMeasuring tissue oxygenation

    Measuring oxygen content of arteries, capillaries and veins

  • Diagnostic testProcalcitonin

    Blood test

    Also known as: PCT

  • Diagnostic testMid-regional proadrenomedullin

    Blood test looking at inflammation in the body

    Also known as: MR-proADM

  • Diagnostic testHand-held video microscope

    A handheld video microscope that looks at blood flow through the capillaries of the tongue

06

What researchers measure

Primary outcomes

  1. Differences in tissue oxygenation

    The difference in tissue oxygen saturation (StO2) during the vascular occlusion test in the Emergency Department between septic patients who need critical care treatment (CCT) compared to patients requiring ward care. This will be measured in % change per second..

    Time frame: Up to 4 hours (from baseline); 28 days (follow-up)

Secondary outcomes

  1. Baseline of tissue oxygenation

    The difference in tissue oxygen saturation (StO2) at baseline in the Emergency Department between septic patients who need critical care treatment (CCT) compared to patients requiring ward care. This will be measured in %.

    Time frame: Up to 4 hours (from baseline); 28 days (follow-up)

  2. Difference in blood flow of the micro-circulation (microvascular flow index)

    Differences in the flow of blood through small blood vessels underneath the tongue between the difference between septic patients who need critical care treatment (CCT) compared to patients requiring ward care. This will be measured by the Microvascular Flow Index (arbitrary units) which is a validated measurement assessing micro-circulatory flow.

    Time frame: Up to 4 hours (from baseline); 28 days (follow-up)

  3. Difference in blood flow of the micro-circulation (perfused vessel density)

    Differences in the flow of blood through small blood vessels underneath the tongue between the difference between septic patients who need critical care treatment (CCT) compared to patients requiring ward care. This will be measured by the perfused vessel density (measured in mm/mm2) which is a validated measurement assessing micro-circulatory flow.

    Time frame: Up to 4 hours (from baseline); 28 days (follow-up)

  4. Difference in blood lactate levels

    The difference in the blood tests of lactate between septic patients who need critical care treatment (CCT) compared to patients requiring ward care

    Time frame: Up to 4 hours (from baseline); 28 days (follow-up)

  5. Difference in blood tests (MR-proADM)

    The difference in the blood tests of MR-proADM between septic patients who need critical care treatment (CCT) compared to patients requiring ward care

    Time frame: Up to 4 hours (from baseline); 28 days (follow-up)

  6. Difference in blood tests (Procalcitonin)

    The difference in the blood tests of Procalcitonin (PCT) between septic patients who need critical care treatment (CCT) compared to patients requiring ward care

    Time frame: Up to 4 hours (from baseline); 28 days (follow-up)

  7. Correlation of extra investigations with standard patient outcomes

    Looking at whether tissue oxygenation, buccal microcirculation (blood flow under the tongue) and biomarkers and correlation with clinical outcomes such as organ failure (SOFA) scores, 28-day hospital mortality, and length of hospital and ICU stay.

    Time frame: Up to 4 hours (from baseline); 28 days (follow-up)

07

Study locations

1 of 1 sites recruiting
  • University Hospital Southampton NHS Foundation Trust
    Southampton, Hampshire SO16 6YD, United Kingdom
    Recruiting
    • James N Ward, BM · Contact
08

References and documents

Publications

  • Hernandez G, Ospina-Tascon GA, Damiani LP, Estenssoro E, Dubin A, Hurtado J, Friedman G, Castro R, Alegria L, Teboul JL, Cecconi M, Ferri G, Jibaja M, Pairumani R, Fernandez P, Barahona D, Granda-Luna V, Cavalcanti AB, Bakker J; The ANDROMEDA SHOCK Investigators and the Latin America Intensive Care Network (LIVEN); Hernandez G, Ospina-Tascon G, Petri Damiani L, Estenssoro E, Dubin A, Hurtado J, Friedman G, Castro R, Alegria L, Teboul JL, Cecconi M, Cecconi M, Ferri G, Jibaja M, Pairumani R, Fernandez P, Barahona D, Cavalcanti AB, Bakker J, Hernandez G, Alegria L, Ferri G, Rodriguez N, Holger P, Soto N, Pozo M, Bakker J, Cook D, Vincent JL, Rhodes A, Kavanagh BP, Dellinger P, Rietdijk W, Carpio D, Pavez N, Henriquez E, Bravo S, Valenzuela ED, Vera M, Dreyse J, Oviedo V, Cid MA, Larroulet M, Petruska E, Sarabia C, Gallardo D, Sanchez JE, Gonzalez H, Arancibia JM, Munoz A, Ramirez G, Aravena F, Aquevedo A, Zambrano F, Bozinovic M, Valle F, Ramirez M, Rossel V, Munoz P, Ceballos C, Esveile C, Carmona C, Candia E, Mendoza D, Sanchez A, Ponce D, Ponce D, Lastra J, Nahuelpan B, Fasce F, Luengo C, Medel N, Cortes C, Campassi L, Rubatto P, Horna N, Furche M, Pendino JC, Bettini L, Lovesio C, Gonzalez MC, Rodruguez J, Canales H, Caminos F, Galletti C, Minoldo E, Aramburu MJ, Olmos D, Nin N, Tenzi J, Quiroga C, Lacuesta P, Gaudin A, Pais R, Silvestre A, Olivera G, Rieppi G, Berrutti D, Ochoa M, Cobos P, Vintimilla F, Ramirez V, Tobar M, Garcia F, Picoita F, Remache N, Granda V, Paredes F, Barzallo E, Garces P, Guerrero F, Salazar S, Torres G, Tana C, Calahorrano J, Solis F, Torres P, Herrera L, Ornes A, Perez V, Delgado G, Lopez A, Espinosa E, Moreira J, Salcedo B, Villacres I, Suing J, Lopez M, Gomez L, Toctaquiza G, Cadena Zapata M, Orazabal MA, Pardo Espejo R, Jimenez J, Calderon A, Paredes G, Barberan JL, Moya T, Atehortua H, Sabogal R, Ortiz G, Lara A, Sanchez F, Hernan Portilla A, Davila H, Mora JA, Calderon LE, Alvarez I, Escobar E, Bejarano A, Bustamante LA, Aldana JL. Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial. JAMA. 2019 Feb 19;321(7):654-664. doi: 10.1001/jama.2019.0071. PubMed 30772908 ↗
  • Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, Mcintyre L, Ostermann M, Prescott HC, Schorr C, Simpson S, Wiersinga WJ, Alshamsi F, Angus DC, Arabi Y, Azevedo L, Beale R, Beilman G, Belley-Cote E, Burry L, Cecconi M, Centofanti J, Coz Yataco A, De Waele J, Dellinger RP, Doi K, Du B, Estenssoro E, Ferrer R, Gomersall C, Hodgson C, Hylander Moller M, Iwashyna T, Jacob S, Kleinpell R, Klompas M, Koh Y, Kumar A, Kwizera A, Lobo S, Masur H, McGloughlin S, Mehta S, Mehta Y, Mer M, Nunnally M, Oczkowski S, Osborn T, Papathanassoglou E, Perner A, Puskarich M, Roberts J, Schweickert W, Seckel M, Sevransky J, Sprung CL, Welte T, Zimmerman J, Levy M. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med. 2021 Nov 1;49(11):e1063-e1143. doi: 10.1097/CCM.0000000000005337. No abstract available. PubMed 34605781 ↗
  • Parrott F. Length of stay , survival and organ support of admissions with septic shock to adult , general critical care units in England , Wales and Northern Ireland. 2014.
  • Liu Z, Meng Z, Li Y, Zhao J, Wu S, Gou S, Wu H. Prognostic accuracy of the serum lactate level, the SOFA score and the qSOFA score for mortality among adults with Sepsis. Scand J Trauma Resusc Emerg Med. 2019 Apr 30;27(1):51. doi: 10.1186/s13049-019-0609-3. PubMed 31039813 ↗
  • Sepsis: recognition, diagnosis and early management: (c) NICE (2017) Sepsis: recognition, diagnosis and early management. BJU Int. 2018 Apr;121(4):497-514. doi: 10.1111/bju.14179. No abstract available. PubMed 29603898 ↗
  • Jones S, Moulton C, Swift S, Molyneux P, Black S, Mason N, Oakley R, Mann C. Association between delays to patient admission from the emergency department and all-cause 30-day mortality. Emerg Med J. 2022 Mar;39(3):168-173. doi: 10.1136/emermed-2021-211572. Epub 2022 Jan 18. PubMed 35042695 ↗
  • Linder A, Arnold R, Boyd JH, Zindovic M, Zindovic I, Lange A, Paulsson M, Nyberg P, Russell JA, Pritchard D, Christensson B, Akesson P. Heparin-Binding Protein Measurement Improves the Prediction of Severe Infection With Organ Dysfunction in the Emergency Department. Crit Care Med. 2015 Nov;43(11):2378-86. doi: 10.1097/CCM.0000000000001265. PubMed 26468696 ↗
  • NHS Digital. Hospital Accident & Emergency Activity 2021-2022. 2022.
  • Adhikari NK, Fowler RA, Bhagwanjee S, Rubenfeld GD. Critical care and the global burden of critical illness in adults. Lancet. 2010 Oct 16;376(9749):1339-46. doi: 10.1016/S0140-6736(10)60446-1. Epub 2010 Oct 11. PubMed 20934212 ↗
  • NHS England (NHS-E). Critical Care Bed Capacity and Urgent Operations Cancelled 2019-20 Data.
  • Simpson HK, Clancy M, Goldfrad C, Rowan K. Admissions to intensive care units from emergency departments: a descriptive study. Emerg Med J. 2005 Jun;22(6):423-8. doi: 10.1136/emj.2003.005124. PubMed 15911950 ↗
  • Diagnostics Assessment Programme Diagnosis and monitoring of sepsis : procalcitonin testing ( ADVIA Centaur BRAHMS PCT assay , BRAHMS PCT Sensitive Kryptor assay , Elecsys BRAHMS PCT assay , LIAISON BRAHMS PCT assay. 2014.
  • Dilken O, Ergin B, Ince C. Assessment of sublingual microcirculation in critically ill patients: consensus and debate. Ann Transl Med. 2020 Jun;8(12):793. doi: 10.21037/atm.2020.03.222. PubMed 32647718 ↗
  • Ait-Oufella H, Lemoinne S, Boelle PY, Galbois A, Baudel JL, Lemant J, Joffre J, Margetis D, Guidet B, Maury E, Offenstadt G. Mottling score predicts survival in septic shock. Intensive Care Med. 2011 May;37(5):801-7. doi: 10.1007/s00134-011-2163-y. Epub 2011 Mar 4. PubMed 21373821 ↗
  • Falotico JM, Shinozaki K, Saeki K, Becker LB. Advances in the Approaches Using Peripheral Perfusion for Monitoring Hemodynamic Status. Front Med (Lausanne). 2020 Dec 7;7:614326. doi: 10.3389/fmed.2020.614326. eCollection 2020. PubMed 33365323 ↗
  • Vorwerk C, Coats TJ. The prognostic value of tissue oxygen saturation in emergency department patients with severe sepsis or septic shock. Emerg Med J. 2012 Sep;29(9):699-703. doi: 10.1136/emermed-2011-200160. Epub 2011 Sep 21. PubMed 21946179 ↗
  • Haertel F, Reisberg D, Peters M, Nuding S, Schroeder J, Werdan K, Ebelt H. Prognostic Value of Tissue Oxygen Saturation Using a Vascular Occlusion Test in Patients in the Early Phase of Multiorgan Dysfunction Syndrome. Shock. 2019 Jun;51(6):706-712. doi: 10.1097/SHK.0000000000001225. PubMed 30052575 ↗
  • AnaesthesiaUK. Principles of pulse oximetry [Internet]. AnaesthesiaUK. 2004. Available from: https://www.frca.co.uk/article.aspx?articleid=332
  • Lipcsey M, Eastwood GM, Woinarski NC, Bellomo R. Near-infrared spectroscopy of the thenar eminence: comparison of dynamic testing protocols. Crit Care Resusc. 2012 Jun;14(2):142-7. PubMed 22697622 ↗
  • Macdonald SP, Brown SG. Near-infrared spectroscopy in the assessment of suspected sepsis in the emergency department. Emerg Med J. 2015 May;32(5):404-8. doi: 10.1136/emermed-2013-202956. Epub 2013 Oct 23. PubMed 24154943 ↗
  • Pinsky MR. Functional hemodynamic monitoring. Crit Care Clin. 2015 Jan;31(1):89-111. doi: 10.1016/j.ccc.2014.08.005. PubMed 25435480 ↗
  • Guyette FX, Gomez H, Suffoletto B, Quintero J, Mesquida J, Kim HK, Hostler D, Puyana JC, Pinsky MR. Prehospital dynamic tissue oxygen saturation response predicts in-hospital lifesaving interventions in trauma patients. J Trauma Acute Care Surg. 2012 Apr;72(4):930-5. doi: 10.1097/TA.0b013e31823d0677. PubMed 22491607 ↗
  • De Backer D, Hollenberg S, Boerma C, Goedhart P, Buchele G, Ospina-Tascon G, Dobbe I, Ince C. How to evaluate the microcirculation: report of a round table conference. Crit Care. 2007;11(5):R101. doi: 10.1186/cc6118. PubMed 17845716 ↗
  • Thooft A, Favory R, Salgado DR, Taccone FS, Donadello K, De Backer D, Creteur J, Vincent JL. Effects of changes in arterial pressure on organ perfusion during septic shock. Crit Care. 2011;15(5):R222. doi: 10.1186/cc10462. Epub 2011 Sep 21. PubMed 21936903 ↗
  • Scorcella C, Damiani E, Domizi R, Pierantozzi S, Tondi S, Carsetti A, Ciucani S, Monaldi V, Rogani M, Marini B, Adrario E, Romano R, Ince C, Boerma EC, Donati A. MicroDAIMON study: Microcirculatory DAIly MONitoring in critically ill patients: a prospective observational study. Ann Intensive Care. 2018 May 15;8(1):64. doi: 10.1186/s13613-018-0411-9. PubMed 29766322 ↗
  • Massey MJ, Shapiro NI. A guide to human in vivo microcirculatory flow image analysis. Crit Care. 2016 Feb 10;20:35. doi: 10.1186/s13054-016-1213-9. PubMed 26861691 ↗
  • Andaluz-Ojeda D, Nguyen HB, Meunier-Beillard N, Cicuendez R, Quenot JP, Calvo D, Dargent A, Zarca E, Andres C, Nogales L, Eiros JM, Tamayo E, Gandia F, Bermejo-Martin JF, Charles PE. Superior accuracy of mid-regional proadrenomedullin for mortality prediction in sepsis with varying levels of illness severity. Ann Intensive Care. 2017 Dec;7(1):15. doi: 10.1186/s13613-017-0238-9. Epub 2017 Feb 10. PubMed 28185230 ↗
  • Saeed K, Legramante JM, Angeletti S, Curcio F, Miguens I, Poole S, Tascini C, Sozio E, Del Castillo JG. Mid-regional pro-adrenomedullin as a supplementary tool to clinical parameters in cases of suspicion of infection in the emergency department. Expert Rev Mol Diagn. 2021 Apr;21(4):397-404. doi: 10.1080/14737159.2021.1902312. Epub 2021 Mar 29. PubMed 33736553 ↗
  • Baldira J, Ruiz-Rodriguez JC, Wilson DC, Ruiz-Sanmartin A, Cortes A, Chiscano L, Ferrer-Costa R, Comas I, Larrosa N, Fabrega A, Gonzalez-Lopez JJ, Ferrer R. Biomarkers and clinical scores to aid the identification of disease severity and intensive care requirement following activation of an in-hospital sepsis code. Ann Intensive Care. 2020 Jan 15;10(1):7. doi: 10.1186/s13613-020-0625-5. PubMed 31940096 ↗
  • Ma H, Liu H, Wu C, Huang L. Diagnostic Value of Serum Heparin Binding Protein, Blood Lactic Acid Combined with hs-CRP in Sepsis and Its Relationship with Prognosis. Evid Based Complement Alternat Med. 2021 Nov 9;2021:5023733. doi: 10.1155/2021/5023733. eCollection 2021. PubMed 34795784 ↗
  • Royal College of Physicians. National Early Warning Score (NEWS) 2: Standardising the assessment of acute-illness severity in the NHS. Vol. 17, Updated report of a working party. London; 2017. 318-318 p.
  • You JS, Park YS, Chung SP, Lee HS, Jeon S, Kim WY, Shin TG, Jo YH, Kang GH, Choi SH, Suh GJ, Ko BS, Han KS, Shin JH, Kong T; Korean Shock Society (KoSS) Investigators. Relationship between time of emergency department admission and adherence to the Surviving Sepsis Campaign bundle in patients with septic shock. Crit Care. 2022 Feb 11;26(1):43. doi: 10.1186/s13054-022-03899-0. PubMed 35148797 ↗
  • Massey MJ, Larochelle E, Najarro G, Karmacharla A, Arnold R, Trzeciak S, Angus DC, Shapiro NI. The microcirculation image quality score: development and preliminary evaluation of a proposed approach to grading quality of image acquisition for bedside videomicroscopy. J Crit Care. 2013 Dec;28(6):913-7. doi: 10.1016/j.jcrc.2013.06.015. Epub 2013 Aug 21. PubMed 23972316 ↗

Individual participant data

Plan to share: Yes — Individual participant data (IPD) that underlie results in a publication will be shared

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: 6 months after publication

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2024 (actual). Primary completion is estimated for Aug 2025, 18 months after the start.

Of 496 non-industry observational studies under Sepsis, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 57. This study's planned 18 months is below that.

Counting every sponsor, half of 548 studies reached it within 27 months; a quarter within 12 and three quarters within 55.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 8, 2024
First posted
Feb 12, 2024
StartActual
Jan 12, 2024
Primary completionEst.
Aug 6, 2025
CompletionEst.
Aug 6, 2025
Last update
Dec 2, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 2, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06253325
Responsible party
Sponsor
First posted
Feb 12, 2024
Start date
Jan 12, 2024
Primary completion
Aug 6, 2025 (estimated)
Completion
Aug 6, 2025 (estimated)
Last update
Dec 2, 2024

Study contacts

James N Ward, BM
Contact
wardj@doctors.org.uk
+447881967336
Ahilanandan Dushianthan, PhD
Contact
a.dushianthan@soton.ac.uk
+447903943418
Ahilanandan Dushianthan, PhD
study director · University Hospital Southampton NHS Foundation Trust
James N Ward, BM
principal investigator · University Hospital Southampton NHS Foundation Trust

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion